AANEM Practice News Express

AANEM News Express

High Risk of Cancer in Autoimmune Necrotizing Myopathies: Usefulness of Myositis Specific Antibody

This study in Brain sheds light on the relationship between necrotizing autoimmune myopathy antibody status and malignancy.

Myasthenia Gravis Treated with Autologous Hematopoietic Stem Cell Transplantation

This study in JAMA Neurology is a retrospective case series on refractory myasthenia gravis treated by hematopoietic stem cell transplantation.

Simmons Named New Muscle & Nerve Editor-In-Chief

The AANEM is pleased to announce the selection of Zachary Simmons, MD, as the new Editor-in-Chief of Muscle & Nerve, beginning with the January 2017 issue.

Clinical Characteristics of Patients with Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

The objective of this study in JAMA Neurology of patients with myasthenia gravis was to determine the characteristics of patients negative for both acetylcholine receptor antibodies (AchR Ab) and MuSK antibodies and positive for cortactin antibodies and compare them with seropositive patients.

2017 Physician Fee Schedule Final Rule—What Does This Rule Mean for Reimbursement?

On November 2, 2016, the Center for Medicare and Medicaid Services (CMS) issued the final rule updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017. Following is a summary of some of the changes affecting reimbursement for AANEM members for the calendar year (CY) 2017.

MACRA Resources For Members Available

After reviewing all 2398 pages of the final MACRA rule, AANEM policy staff have worked diligently to create resources for members to help them understand the key provisions of this complex ruling and how it will affect their practices.

CMS Releases Final Rule: 2017 Medicare Physician Fee Schedule

On November 2, 2016, the Centers for Medicare & Medicaid Services (CMS) issued the
final rule updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017.  CMS estimates a 0% impact in payment on neurology and physical medicine and rehabilitation physicians.

Updates to AANEM Disciplinary Policies and Procedures

Under the direction of David A. Simpson, DO, and Raghav Govindarajan, MD, the Ethics and Peer Review Committee has updated, and the AANEM Board of Directors has approved, the AANEM Disciplinary Policies and Procedures. The procedures were initially adopted in 1995 to enable fair and impartial review of complaints of professional misconduct concerning AANEM members, and, when appropriate, to pursue disciplinary action.

Learn About NCS Normal Values Through Podcast & Publications

The AANEM Normative Data Taskforce (NDTF) reports on establishing high quality reference values for nerve conduction studies (NCSs) were published in the September issue of Muscle & Nerve. Because there are not uniform standards for NCSs in the United States, taskforce members reviewed over 7500 articles to identify high quality studies regarding nerve conduction techniques and reference values for commonly tested upper and lower limb nerves. Following the publications, Ted M. Burns, MD, of the AANEM Podcast Editorial Board interviewed NDTF Chair Timothy R. Dillingham, MD.

Rate of Disease Progression: A Prognostic Biomarker in ALS

While the conclusion that a faster rate of progression at initial assessment of a patient with ALS portends a poorer prognosis is intuitive, this study in the Journal of Neurology, Neurosurgery & Psychiatry provides more precise quantification of this phenomenon.







Devon products